Delivery Order SPE2DB22D1002-SPE2DB24FLAT3

Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $3.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A 2ML injectables. The contract has a ceiling value of $2,350.50 and is a firm fixed price delivery order with a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a prescription medication, at a ceiling value of $8,937.10. The order has a firm fixed price and an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of Bicillin L-A, a penicillin-based antibiotic, in 2 milliliter vials. The $1,175.24 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $1,327.87 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of January 31, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of the pharmaceutical product Bicillin L-A in 2ml vials. The $10,065.30 contract has a completion date of May 1, 2024 and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of 2ml Bicillin L-A medication. The order, valued at $1,175.24, has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,200,000 units of 2ml Bicillin L-A, a pharmaceutical product, with a potential value of $1,175.24. This award has a completion date of February 15, 2024 and was made on February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,175.24, is for the delivery of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2ML vials. The contract is a firm fixed-price arrangement, with a period of performance through September 13, 2024. This order is not set aside for any specific business category. Amerisourcebergen is a major supplier of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,305.10 fixed-price delivery order is for the procurement of 1,200,000 units of Bicillin L-A, a prescription medication. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract, valued at $3,525.75, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLAT3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200,000 units of the pharmaceutical product Bicillin L-A in 2 milliliter vials. The contract has a firm fixed price of $3,218.58 and an ultimate completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order was awarded on a full and open competition basis without a set-aside designation.

Generated 7/15/24, 6:45 PM